Recombinant multi-species RANTES/CCL5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RANTES/CCL5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is one of several chemokine genes clustered on the q-arm of chromosome 17. Chemokines form a superfamily of secreted proteins involved in immunoregulatory and inflammatory processes. The superfamily is divided into four subfamilies based on the arrangement of the N-terminal cysteine residues of the mature peptide. This chemokine, a member of the CC subfamily, functions as a chemoattractant for blood monocytes, memory T helper cells and eosinophils. It causes the release of histamine from basophils and activates eosinophils. This cytokine is one of the major HIV-suppressive factors produced by CD8+ cells. It functions as one of the natural ligands for the chemokine receptor chemokine (C-C motif) receptor 5 (CCR5), and it suppresses in vitro replication of the R5 strains of HIV-1, which use CCR5 as a coreceptor. Alternative splicing results in multiple transcript variants that encode different isoforms. [provided by RefSeq, Jul 2013]
The Alternative Names of target: C-C motif chemokine 5,CCL5,Ccl5,D17S136E,EoCP,Eosinophil chemotactic cytokine,MuRantes,RANTES,Rantes,SCYA5,SIS-delta,SISd,Scya5,Small-inducible cytokine A5,T cell-specific protein P228 (TCP228),T-cell-specific protein RANTES,TCP228,eoCP
Go
to RANTES/CCL5 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T16263-Ag-1/ GM-Tg-hg-T16263-Ag-2 | Human RANTES/CCL5 protein | Human |
| GM-Tg-rg-T16263-Ag-1/ GM-Tg-rg-T16263-Ag-2 | Rat RANTES/CCL5 protein | Rat |
| GM-Tg-mg-T16263-Ag-1/ GM-Tg-mg-T16263-Ag-2 | Mouse RANTES/CCL5 protein | Mouse |
| GM-Tg-cynog-T16263-Ag-1/ GM-Tg-cynog-T16263-Ag-2 | Cynomolgus/Rhesus macaque RANTES/CCL5 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T16263-Ag-1/ GM-Tg-felg-T16263-Ag-2 | Feline RANTES/CCL5 protein | Feline |
| GM-Tg-cang-T16263-Ag-1/ GM-Tg-cang-T16263-Ag-2 | Canine RANTES/CCL5 protein | Canine |
| GM-Tg-bovg-T16263-Ag-1/ GM-Tg-bovg-T16263-Ag-2 | Bovine RANTES/CCL5 protein | Bovine |
| GM-Tg-equg-T16263-Ag-1/ GM-Tg-equg-T16263-Ag-2 | Equine RANTES/CCL5 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T16263-Ag-1/ GM-Tg-hg-T16263-Ag-2;
GM-Tg-rg-T16263-Ag-1/ GM-Tg-rg-T16263-Ag-2;
GM-Tg-mg-T16263-Ag-1/ GM-Tg-mg-T16263-Ag-2; GM-Tg-cynog-T16263-Ag-1/ GM-Tg-cynog-T16263-Ag-2; GM-Tg-felg-T16263-Ag-1/ GM-Tg-felg-T16263-Ag-2; GM-Tg-cang-T16263-Ag-1/ GM-Tg-cang-T16263-Ag-2; GM-Tg-bovg-T16263-Ag-1/ GM-Tg-bovg-T16263-Ag-2; GM-Tg-equg-T16263-Ag-1/ GM-Tg-equg-T16263-Ag-2 |
| Products Name | RANTES/CCL5 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | RANTES/CCL5 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RANTES/CCL5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.